Related Experiment Video
Updated: Dec 19, 2025
Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
Published on: February 16, 2022
A serological assay to detect SARS-CoV-2 seroconversion in humans.
Fatima Amanat1,2, Daniel Stadlbauer1, Shirin Strohmeier1,3
1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Researchers developed sensitive and specific enzyme-linked immunosorbent assays (ELISA) to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies. These assays can identify COVID-19 seroconverters early and aid in determining population immunity.
Area of Science:
- Immunology
- Virology
- Biotechnology
Background:
- The COVID-19 pandemic, caused by SARS-CoV-2, highlighted the need for reliable serological assays.
- Existing molecular tests diagnose acute infection but do not assess past exposure or immunity.
- Development of specific serological tests for SARS-CoV-2 antibodies is crucial.
Conclusions:
- The developed ELISA assays are valuable tools for COVID-19 diagnosis and epidemiological studies.
- These assays can determine seroprevalence, identify past exposure, and aid in convalescent serum generation.
- Future applications include screening healthcare workers for immunity to optimize patient care and minimize viral spread.
More Related Videos
07:08A Rapid, Multiplex Dual Reporter IgG and IgM SARS-CoV-2 Neutralization Assay for a Multiplexed Bead-Based Flow Analysis System
Published on: April 6, 2021
10:25Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
Published on: June 5, 2021
